Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Addeo

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Cancer Treatment Reviews|February 26, 2022
Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]Alex Friedlaender, Jarushka Naidoo, Giuseppe Luigi Banna, et al.
Cancer Treatment Reviews|April 2, 2021
Immunotherapy in non-small cell lung cancer harbouring driver mutationsAlfredo Addeo, Antonio Passaro, Umberto Malapelle, et al.
Case Reports in Oncology|April 15, 2024
Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case ReportXavier Baer, Mathieu Chevallier, Juliana Rey Cobo, et al.
International Journal of Surgery Case Reports|March 3, 2012
Phytobezoar in Meckel's diverticulum: A rare cause of small bowel obstructionRoberto Bini, Fabrizio Quiriconi, Aurelio Tello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2024
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief ReportDaniele Tavernari, Maxime Borgeaud, Ximeng Liu, et al.
Revue Medicale Suisse|March 30, 2022
[Patient involvement in oncology research - Development of a reference framework in French-speaking Switzerland]Sara Colomer-Lahiguera, Tourane Corbière, Frédérique Reeb-Landry, et al.
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Immunotargets and Therapy|June 30, 2021
VISTA: A Promising Target for Cancer Immunotherapy?Marco Tagliamento, Elisa Agostinetto, Roberto Borea, et al.
Critical Reviews in Oncology/Hematology|September 29, 2019
Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debateCristina Picardi, Francesca Caparroti, Massimo Di Maio, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Cancer Treatment Reviews|February 26, 2022
Corrigendum to "Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC" [Cancer Treat. Rev. 104 (2022) 102350]Alex Friedlaender, Jarushka Naidoo, Giuseppe Luigi Banna, et al.
Cancer Treatment Reviews|April 2, 2021
Immunotherapy in non-small cell lung cancer harbouring driver mutationsAlfredo Addeo, Antonio Passaro, Umberto Malapelle, et al.
Case Reports in Oncology|April 15, 2024
Rare Synchronous Lung Cancers in a Nonsmoker with Epidermal Growth Factor Receptor and Mesenchymal-Epithelial Transition Alterations: A Case ReportXavier Baer, Mathieu Chevallier, Juliana Rey Cobo, et al.
International Journal of Surgery Case Reports|March 3, 2012
Phytobezoar in Meckel's diverticulum: A rare cause of small bowel obstructionRoberto Bini, Fabrizio Quiriconi, Aurelio Tello, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 18, 2024
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief ReportDaniele Tavernari, Maxime Borgeaud, Ximeng Liu, et al.
Revue Medicale Suisse|March 30, 2022
[Patient involvement in oncology research - Development of a reference framework in French-speaking Switzerland]Sara Colomer-Lahiguera, Tourane Corbière, Frédérique Reeb-Landry, et al.
Cancer Treatment Reviews|August 21, 2023
Novel targets for immune-checkpoint inhibition in cancerMaxime Borgeaud, Jose Sandoval, Michel Obeid, et al.
Immunotargets and Therapy|June 30, 2021
VISTA: A Promising Target for Cancer Immunotherapy?Marco Tagliamento, Elisa Agostinetto, Roberto Borea, et al.
Critical Reviews in Oncology/Hematology|September 29, 2019
Prophylactic cranial irradiation in extensive disease small cell lung cancer: An endless debateCristina Picardi, Francesca Caparroti, Massimo Di Maio, et al.
Nature Reviews. Clinical Oncology|September 25, 2021
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatmentAlex Friedlaender, Vivek Subbiah, Alessandro Russo, et al.
Pageof 23